BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16962610)

  • 1. Directed evolution of an anti-prion protein scFv fragment to an affinity of 1 pM and its structural interpretation.
    Luginbühl B; Kanyo Z; Jones RM; Fletterick RJ; Prusiner SB; Cohen FE; Williamson RA; Burton DR; Plückthun A
    J Mol Biol; 2006 Oct; 363(1):75-97. PubMed ID: 16962610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Affinity maturation of phage display antibody populations using ribosome display.
    Groves M; Lane S; Douthwaite J; Lowne D; Rees DG; Edwards B; Jackson RH
    J Immunol Methods; 2006 Jun; 313(1-2):129-39. PubMed ID: 16730741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
    Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
    J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species-specificity of a panel of prion protein antibodies for the immunohistochemical study of animal and human prion diseases.
    Furuoka H; Yabuzoe A; Horiuchi M; Tagawa Y; Yokoyama T; Yamakawa Y; Shinagawa M; Sata T
    J Comp Pathol; 2007 Jan; 136(1):9-17. PubMed ID: 17270205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro evolution of single-chain antibodies using mRNA display.
    Fukuda I; Kojoh K; Tabata N; Doi N; Takashima H; Miyamoto-Sato E; Yanagawa H
    Nucleic Acids Res; 2006; 34(19):e127. PubMed ID: 17012279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection for improved protein stability by phage display.
    Jung S; Honegger A; Plückthun A
    J Mol Biol; 1999 Nov; 294(1):163-80. PubMed ID: 10556036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Picomolar affinity antibodies from a fully synthetic naive library selected and evolved by ribosome display.
    Hanes J; Schaffitzel C; Knappik A; Plückthun A
    Nat Biotechnol; 2000 Dec; 18(12):1287-92. PubMed ID: 11101809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
    Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M
    Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new yeast display vector permitting free scFv amino termini can augment ligand binding affinities.
    Wang Z; Mathias A; Stavrou S; Neville DM
    Protein Eng Des Sel; 2005 Jul; 18(7):337-43. PubMed ID: 15976011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A human antibody fragment with high affinity for biodegradable polymer film.
    Watanabe H; Tsumoto K; Taguchi S; Yamashita K; Doi Y; Nishimiya Y; Kondo H; Umetsu M; Kumagai I
    Bioconjug Chem; 2007; 18(3):645-51. PubMed ID: 17385839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel single chain antibodies to the prion protein identified by phage display.
    Adamson CS; Yao Y; Vasiljevic S; Sy MS; Ren J; Jones IM
    Virology; 2007 Feb; 358(1):166-77. PubMed ID: 16996555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-estradiol-17beta single-chain Fv fragments: Generation, characterization, gene randomization, and optimized phage display.
    Kobayashi N; Kato Y; Oyama H; Taga S; Niwa T; Sun P; Ohtoyo M; Goto J
    Steroids; 2008 Dec; 73(14):1485-99. PubMed ID: 18824188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single prion protein peptide can elicit a panel of isoform specific monoclonal antibodies.
    Vranac T; Hartman KP; Popović M; Venturini A; Zerovnik E; Curin Serbec V
    Peptides; 2006 Nov; 27(11):2695-705. PubMed ID: 16859811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Directed in vitro evolution and crystallographic analysis of a peptide-binding single chain antibody fragment (scFv) with low picomolar affinity.
    Zahnd C; Spinelli S; Luginbühl B; Amstutz P; Cambillau C; Plückthun A
    J Biol Chem; 2004 Apr; 279(18):18870-7. PubMed ID: 14754898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementarity determining regions of an anti-prion protein scFv fragment orchestrate conformation specificity and antiprion activity.
    Müller-Schiffmann A; Petsch B; Leliveld SR; Muyrers J; Salwierz A; Mangels C; Schwarzinger S; Riesner D; Stitz L; Korth C
    Mol Immunol; 2009 Feb; 46(4):532-40. PubMed ID: 18973947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-chain Fv antibody fragments retain binding properties of the monoclonal antibody raised against peptide P1 of the human prion protein.
    Skrlj N; Serbec VC; Dolinar M
    Appl Biochem Biotechnol; 2010 Mar; 160(6):1808-21. PubMed ID: 19597999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of human single-chain variable fragment (scFv) antibody specific for digoxin by ribosome display.
    Yan XH; Xu ZR
    Indian J Biochem Biophys; 2005 Dec; 42(6):350-7. PubMed ID: 16955735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of recombinant chicken IgY from single chain fragment of variable region for diagnosis of BSE.
    Miyamoto K; Shimamoto T; Aosasa M; Kimura S; Nakamura N; Okubo Y; Yokoyama T; Horiuchi H; Furusawa S; Matsuda H
    Biologicals; 2007 Mar; 35(1):31-4. PubMed ID: 16580230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-based immunotherapeutic attempts in experimental animal models of prion diseases.
    Sakaguchi S; Ishibashi D; Matsuda H
    Expert Opin Ther Pat; 2009 Jul; 19(7):907-17. PubMed ID: 19514955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single chain Fv antibodies directed against the 37 kDa/67 kDa laminin receptor as therapeutic tools in prion diseases.
    Zuber C; Knackmuss S; Rey C; Reusch U; Röttgen P; Fröhlich T; Arnold GJ; Pace C; Mitteregger G; Kretzschmar HA; Little M; Weiss S
    Mol Immunol; 2008 Jan; 45(1):144-51. PubMed ID: 17576014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.